Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 2,325 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 4,650 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS | 57,292 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | UTENDR | 6,979 | — | — | -10.9% | Open the original filing on SEC.gov |
| Apr 30, 2025 | RGLS | Regulus Therapeutics Inc. | AGRANT | 62,500 | — | — | +3,529% | Open the original filing on SEC.gov |